324 related articles for article (PubMed ID: 18313272)
1. Molecular characterisation of isoniazid-resistant Mycobacterium tuberculosis isolated from new cases in Lagunes region (Côte d'Ivoire).
N'Guessan KR; Dosso M; Ekaza E; Kouakou J; Jarlier V
Int J Antimicrob Agents; 2008 May; 31(5):498-500. PubMed ID: 18313272
[No Abstract] [Full Text] [Related]
2. Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis clinical strains isolated in the Philippines.
Herrera L; Valverde A; Saiz P; Sáez-Nieto JA; Portero JL; Jiménez MS
Int J Antimicrob Agents; 2004 Jun; 23(6):572-6. PubMed ID: 15194127
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization of isoniazid resistance in Mycobacterium tuberculosis: identification of a novel mutation in inhA.
Leung ET; Ho PL; Yuen KY; Woo WL; Lam TH; Kao RY; Seto WH; Yam WC
Antimicrob Agents Chemother; 2006 Mar; 50(3):1075-8. PubMed ID: 16495272
[TBL] [Abstract][Full Text] [Related]
4. [KatG Ser3 15Thr mutation as the main reason of isoniazid resistance in Mycobacterium tuberculosis isolated in the Novosibirsk and Kemerovo Regions].
Voronina EN; Vikhrova MA; Khrapov EA; Kinsht VN; Norkina OV; Gorbunova EV; Shabaldin AV; Glushkov AN; Krasnov VA; Filipenko ML
Mol Gen Mikrobiol Virusol; 2004; (3):8-11. PubMed ID: 15354935
[TBL] [Abstract][Full Text] [Related]
5. Rapid genotypic assays to identify drug-resistant Mycobacterium tuberculosis in South Africa.
Evans J; Stead MC; Nicol MP; Segal H
J Antimicrob Chemother; 2009 Jan; 63(1):11-6. PubMed ID: 18940875
[TBL] [Abstract][Full Text] [Related]
6. katG mutations in isoniazid-resistant strains of Mycobacterium tuberculosis isolates from Belarusian patients.
Zaker Bostanabad S; Titov LP; Slizen VV; Taghikhani M; Bahrmand A
Tuberk Toraks; 2007; 55(3):231-7. PubMed ID: 17978919
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Tunisian Mycobacterium tuberculosis rifampin-resistant clinical isolates.
Soudani A; Hadjfredj S; Zribi M; Masmoudi A; Messaoud T; Tiouri H; Fendri C
J Clin Microbiol; 2007 Sep; 45(9):3095-7. PubMed ID: 17652484
[TBL] [Abstract][Full Text] [Related]
8. Comment on: isoniazid and rifampicin resistance-associated mutations in Mycobacterium tuberculosis isolates from Yangon, Myanmar: implications for rapid molecular testing.
Köser CU; Summers DK; Archer JA
J Antimicrob Chemother; 2011 Mar; 66(3):686-7; author reply 687. PubMed ID: 21177677
[No Abstract] [Full Text] [Related]
9. [Molecular-genetic characteristics of Mycobacterium tuberculosis strains isolated in southern region of Ukraine].
Nikolaevskiĭ VV; Drobniewski FA; Bazhora IuI
Tsitol Genet; 2004; 38(4):23-8. PubMed ID: 15715161
[TBL] [Abstract][Full Text] [Related]
10. Detection of resistance to isoniazid in clinical isolates of Mycobacterium tuberculosis by molecular techniques.
Sharma M; Altamirano M; Prasad HK; Myneedo VP; Nand N
J Assoc Physicians India; 2001 Jul; 49():772-3. PubMed ID: 11573575
[No Abstract] [Full Text] [Related]
11. Isoniazid's bactericidal activity ceases because of the emergence of resistance, not depletion of Mycobacterium tuberculosis in the log phase of growth.
Gumbo T; Louie A; Liu W; Ambrose PG; Bhavnani SM; Brown D; Drusano GL
J Infect Dis; 2007 Jan; 195(2):194-201. PubMed ID: 17191164
[TBL] [Abstract][Full Text] [Related]
12. Lack of correlation between embB mutation and ethambutol MIC in Mycobacterium tuberculosis clinical isolates from China.
Shi R; Zhang J; Otomo K; Zhang G; Sugawara I
Antimicrob Agents Chemother; 2007 Dec; 51(12):4515-7. PubMed ID: 17846128
[TBL] [Abstract][Full Text] [Related]
13. [Identification of Mycobacterium tuberculosis strains and a simultaneous identification of their drug resistance by the hybridization method on oligonucleotide microchips].
Griadunov DA; Mikhaĭlovich VM; Lapa SA; Rudinskiĭ NI; Barskiĭ VE; Chudinov AV; Zasedatelev AS; Mirzabekov AD
Mol Gen Mikrobiol Virusol; 2003; (4):24-7. PubMed ID: 14664159
[TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from India.
Nusrath Unissa A; Selvakumar N; Narayanan S; Narayanan PR
Int J Antimicrob Agents; 2008 Jan; 31(1):71-5. PubMed ID: 18006278
[TBL] [Abstract][Full Text] [Related]
15. The molecular basis of isoniazid resistance in Mycobacterium tuberculosis.
Heym B; Saint-Joanis B; Cole ST
Tuber Lung Dis; 1999; 79(4):267-71. PubMed ID: 10692996
[No Abstract] [Full Text] [Related]
16. Multiple mutations in katG and inhA identified in Thai isoniazid-resistant Mycobacterium tuberculosis isolates.
Khadka DK; Eampokalap B; Panitchakorn J; Ramasoota P; Khusmith S
Southeast Asian J Trop Med Public Health; 2007 Mar; 38(2):376-82. PubMed ID: 17539290
[TBL] [Abstract][Full Text] [Related]
17. Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid.
Vilchèze C; Wang F; Arai M; Hazbón MH; Colangeli R; Kremer L; Weisbrod TR; Alland D; Sacchettini JC; Jacobs WR
Nat Med; 2006 Sep; 12(9):1027-9. PubMed ID: 16906155
[TBL] [Abstract][Full Text] [Related]
18. Public health impact of isoniazid-resistant Mycobacterium tuberculosis strains with a mutation at amino-acid position 315 of katG: a decade of experience in The Netherlands.
van Doorn HR; de Haas PE; Kremer K; Vandenbroucke-Grauls CM; Borgdorff MW; van Soolingen D
Clin Microbiol Infect; 2006 Aug; 12(8):769-75. PubMed ID: 16842572
[TBL] [Abstract][Full Text] [Related]
19. [Detection of wild type isolates and point mutations in genome of isoniazid-resistant Mycobacteria tuberculosis].
Limanskaia OIu; Mukhina TN; Stepanshina VN; Shemiakin IG; Wu X; Zhang J; Fecenko TV; Pokrovskiĭ VA; Limanskiĭ AP
Mol Biol (Mosk); 2010; 44(4):635-45. PubMed ID: 20873222
[TBL] [Abstract][Full Text] [Related]
20. Genetic diversity of isoniazid-resistant Mycobacterium tuberculosis isolates collected in Poland and assessed by spoligotyping.
Augustynowicz-Kopec E; Jagielski T; Zwolska Z
J Clin Microbiol; 2008 Dec; 46(12):4041-4. PubMed ID: 18832130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
